Preview

Medical alphabet

Advanced search

Significance of Gardnerella vaginalis genotyping in diagnosis of recurrent bacterial vaginosis

https://doi.org/10.33667/2078-5631-2021-30-48-52

Abstract

Objective. To assess the importance of identifying different genotypes of Gardnerella vaginalis in the diagnosis of recurrent bacterial vaginosis.

Materials and methods. The study involved 299 women of reproductive age. All patients were divided into three groups (healthy women, women with the first episode of bacterial vaginosis, and women with recurrent bacterial vaginosis). DNA of Gardnerella vaginalis in vaginal discharge was detected by real-time PCR. The detection of four genotypes of G. vaginalis was performed using real-time multiplex PCR. To quantify the amplified PCR fragments, quantitative standard samples were constructed. Statistical analysis of the results was carried out using the statistical package NCSS 11 (NCSS, LCC).

Results. In 38.2 % of healthy women, any one genotype of G. vaginalis was identified in the vaginal biotope, most often it was genotype 4 (35.2 %), while the concentration of G. vaginalis DNA was low (102–103 geqs/ml). When several genotypes of gardnerella were detected simultaneously in healthy women, the DNA concentration did not exceed 104 geqs/ml. A completely different picture was observed among women with bacterial vaginosis (BV). In the first episode of BV, genotype 4 of G. vaginalis prevailed, both as a single genotype and in combination with 1 or 2, or 3 genotypes. In the recurrent course of BV, only 3–4 genotypes of G. vaginalis were detected at once, and in 78 % of cases it had place is a combination of 1, 2 and 4 genotypes, and the DNA concentration was 107–108 geqs/ml.

Conclusion. To diagnose recurrent forms of BV, it is necessary to develop and introduce into practice laboratory diagnostics a test system for detecting different genotypes of G. vaginalis by real-time PCR.

About the Authors

A. A. Krysanova
Scientific and Research Institute for Obstetrics and Gynecology n. a. D. O. Ott; Saint Petersburg State Pediatric Medical University
Russian Federation

Krysanova Anna A., researcher of the Group of Experimental Microbiology; assistant of Dept of Clinical Laboratory Diagnostics

Researcher ID: K‑3678–2018. Scopus: 57199643089

Saint Petersburg



A. E. Gushchin
Moscow Scientific and Practical Centre for Dermatovenereology and Cosmetology
Russian Federation

Gushchin Alexander E., PhD Bio, led. researcher

Saint Petersburg



A. M. Savicheva
Scientific and Research Institute for Obstetrics and Gynecology n. a. D. O. Ott; Saint Petersburg State Pediatric Medical University
Russian Federation

Savicheva Alevtina M., DM Sci (habil.), professor, head of Dept of Medical
Microbiology; head of Dept of Clinical Laboratory Diagnostics

Researcher ID: P‑6788–2015. Scopus: 6602838765

Saint Petersburg



References

1. Shipitsyna E, Khusnutdinova T, Budilovskaya O et al. Bacterial vaginosis-associated vaginal microbiota is an age-independent risk factor for Chlamydia trachomatis, Mycoplasma genitalium and Trichomonas vaginalis infections in low-risk women, St. Petersburg, Russia. Eur J Clin Microbiol Infect Dis. 2020 Jul; 39 (7): 1221–1230. DOI: 10.1007/s10096–020–03831-w. Epub 2020 Feb 8. PMID: 32036466. PMCID: PMC7303053.

2. Schwebke JR, Desmond R. Natural history of asymptomatic bacterial vaginosis in a high-risk group of women. Sexually transmitted diseases. 2007; 34 (11): 876–7. DOI: 10.1097/OLQ.0b013e318073bd82.

3. Oduyebo OO, Anorlu RI, Ogunsola FT. The effects of antimicrobial therapy on bacterial vaginosis in non-pregnant women. Cochrane Database Syst Rev 2009; DOI: 10.1002/14651858.CD006055.pub2.

4. Sobel JD, Schmitt C, Meriwether C. Long-term follow-up of patients with bacterial vaginosis treated with oral metronidazole and topical clindamycin. J Infect Dis. 1993 Mar; 167 (3): 783–4. DOI: 10.1093/infdis/167.3.783. PMID: 8440952.

5. Bradshaw CS, Morton AN, Hocking J, et al. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis. 2006 Jun 1; 193 (11): 1478–86. DOI: 10.1086/503780. Epub 2006 Apr 26. PMID: 16652274.

6. Bradshaw CS, Walker SM, Vodstrcil LA, et.al. The influence of behaviors and relationships on the vaginal microbiota of women and their female partners: the WOW Health Study. J Infect Dis. 2014 May 15; 209 (10): 1562–72. DOI: 10.1093/infdis/jit664. Epub 2013 Nov 27. PMID: 24285846.

7. Vodstrcil LA, Walker SM, Hocking JS, et.al. Incident bacterial vaginosis (BV) in women who have sex with women is associated with behaviors that suggest sexual transmission of BV. Clin Infect Dis. 2015 Apr 1; 60 (7): 1042–53. DOI: 10.1093/cid/ciu1130. Epub 2014 Dec 16. PMID: 25516188.

8. Swidsinski A, Mendling W, Loening-Baucke V, et.al. An adherent Gardnerella vaginalis bioflm persists on the vaginal epithelium after standard therapy with oral metronidazole. Am J Obstet Gynecol. 2008 Jan; 198 (1): 97.e1–6. DOI: 10.1016/j.ajog.2007.06.039. Epub 2007 Nov 19. PMID: 18005928.

9. Swidsinski A, Loening-Baucke V, Mendling W, et.al. Infection through structured polymicrobial Gardnerella bioflms (StPM-GB). Histol Histopathol. 2014 May; 29 (5): 567–87. DOI: 10.14670/HH-29.10.567. Epub 2013 Dec 11. PMID: 24327088.

10. Muzny CA, Schwebke JR. Bioflms: An Underappreciated Mechanism of Treatment Failure and Recurrence in Vaginal Infections. Clin Infect Dis. 2015 Aug 15; 61 (4): 601–6. DOI: 10.1093/cid/civ353. Epub 2015 May 1. PMID: 25935553. PMCID: PMC4607736.

11. Machado A, Cerca N. Influence of Bioflm Formation by Gardnerella vaginalis and Other Anaerobes on Bacterial Vaginosis. J Infect Dis. 2015 Dec 15; 212 (12): 1856–61. DOI: 10.1093/infdis/jiv338. Epub 2015 Jun 16. PMID: 26080369.

12. Castro J, Cerca N. BV and non-BV associated Gardnerella vaginalis establish similar synergistic interactions with other BV-associated microorganisms in dual-species bioflms. Anaerobe. 2015 Dec; 36: 56–9. DOI: 10.1016/j.anaerobe.2015.10.008. Epub 2015 Oct 24. PMID: 26505928.

13. Swidsinski A, Loening-Baucke V, Swidsinski S, Verstraelen H. Polymicrobial Gardnerella bioflm resists repeated intravaginal antiseptic treatment in a subset of women with bacterial vaginosis: a preliminary report. Arch Gynecol Obstet. 2015 Mar; 291 (3): 605–9. DOI: 10.1007/s00404–014–3484–1. Epub 2014 Sep 23. PMID: 25245669.

14. Alves P, Castro J, Sousa C, Cereija TB, Cerca N. Gardnerella vaginalis outcompetes 29 other bacterial species isolated from patients with bacterial vaginosis, using in an in vitro bioflm formation model. J Infect Dis. 2014 Aug 15; 210 (4): 593–6. DOI: 10.1093/infdis/jiu131. Epub 2014 Mar 4. PMID: 24596283.

15. Machado A, Jefferson KK, Cerca N. Interactions between Lactobacillus crispatus and bacterial vaginosis (BV)-associated bacterial species in initial attachment and bioflm formation. Int J Mol Sci. 2013 Jun 5; 14 (6): 12004–12. DOI: 10.3390/ijms140612004. PMID: 23739678. PMCID: PMC3709769.

16. Castro J, Alves P, Sousa C, Cereija T, França Â, Jefferson KK, Cerca N. Using an in-vitro bioflm model to assess the virulence potential of bacterial vaginosis or non-bacterial vaginosis Gardnerella vaginalis isolates. Sci Rep. 2015 Jun 26; 5: 11640. DOI: 10.1038/srep11640. PMID: 26113465. PMCID: PMC4481526.

17. Piot P, Van Dyck E, Peeters M, Hale J, Totten PA, Holmes KK. Biotypes of Gardnerella vaginalis. J Clin Microbiol. 1984 Oct; 20 (4): 677–9. DOI: 10.1128/JCM.20.4.677–679.1984. PMID: 6333436. PMCID: PMC271409.

18. Benito R, Vazquez JA, Berron S, Fenoll A, Saez-Neito JA. A modifed scheme for biotyping Gardnerella vaginalis. J Med Microbiol. 1986 Jun; 21 (4): 357–9. DOI: 10.1099/00222615–21–4–357. PMID: 3088281.

19. Santiago GL, Deschaght P, El Aila N, Kiama TN, Verstraelen H, Jefferson KK, Temmerman M, Vaneechoutte M. Gardnerella vaginalis comprises three distinct genotypes of which only two produce sialidase. Am J Obstet Gynecol. 2011 May; 204 (5): 450. e1–7. DOI: 10.1016/j.ajog.2010.12.061. Epub 2011 Mar 27. PMID: 21444061.

20. Paramel Jayaprakash T, Schellenberg JJ, Hill JE. Resolution and characterization of distinct cpn60-based subgroups of Gardnerella vaginalis in the vaginal microbiota. PLoS One. 2012; 7 (8): e43009. DOI: 10.1371/journal.pone.0043009. Epub 2012 Aug 10. PMID: 22900080. PMCID: PMC3416817.

21. Ahmed A, Earl J, Retchless A, Hillier SL, Rabe LK, Cherpes TL, Powell E, Janto B, Eutsey R, Hiller NL, Boissy R, Dahlgren ME, Hall BG, Costerton JW, Post JC, Hu FZ, Ehrlich GD. Comparative genomic analyses of 17 clinical isolates of Gardnerella vaginalis provide evidence of multiple genetically isolated clades consistent with subspeciation into genovars. J Bacteriol. 2012 Aug; 194 (15): 3922–37. DOI: 10.1128/JB.00056–12. Epub 2012 May 18. PMID: 22609915. PMCID: PMC3416530.

22. Lewis WG, Robinson LS, Gilbert NM, Perry JC, Lewis AL. Degradation, foraging, and depletion of mucus sialoglycans by the vagina-adapted Actinobacterium Gardnerella vaginalis. J Biol Chem. 2013 Apr 26; 288 (17): 12067–79. DOI: 10.1074/jbc.M113.453654. Epub 2013 Mar 11. PMID: 23479734. PMCID: PMC3636892.

23. Briselden AM, Moncla BJ, Stevens CE, Hillier SL. Sialidases (neuraminidases) in bacterial vaginosis and bacterial vaginosis-associated microflora. J Clin Microbiol. 1992 Mar; 30 (3): 663–6. DOI: 10.1128/JCM.30.3.663–666.1992. PMID: 1551983. PMCID: PMC265128.

24. Swidsinski A, Doerffel Y, Loening-Baucke V, Swidsinski S, Verstraelen H, Vaneechoutte M, Lemm V, Schilling J, Mendling W. Gardnerella biofilm involves females and males and is transmitted sexually. Gynecol Obstet Invest. 2010; 70 (4): 256–63. DOI: 10.1159/000314015. Epub 2010 Oct 16. PMID: 21051845.

25. Vaneechoutte M, Guschin A, Van Simaey L, Gansemans Y, Van Nieuwerburgh F, Cools P. Emended description of Gardnerella vaginalis and description of Gardnerella leopoldii sp. nov., Gardnerella piotii sp. nov. and Gardnerella swidsinskii sp. nov., with delineation of 13 genomic species within the genus Gardnerella. Int J Syst Evol Microbiol. 2019 Mar; 69 (3): 679–687. DOI: 10.1099/ijsem.0.003200. Epub 2019 Jan 16. PMID: 30648938.

26. Brooke M Faught 1, Sonia Reyes J Womens Health (Larchmt) 2019 Sep; 28 (9): 1218–1226. Characterization and Treatment of Recurrent Bacterial Vaginosis DOI: 10.1089/jwh.2018.7383.

27. Balashov SV, Mordechai E, Adelson ME, Gygax SE. Identifcation, quantifcation and subtyping of Gardnerella vaginalis in noncultured clinical vaginal samples by quantitative PCR. J Med Microbiol. 2014 Feb; 63 (Pt 2): 162–175. DOI: 10.1099/jmm.0.066407–0. Epub 2013 Nov 7. PMID: 24200640.

28. Zozaya-Hinchliffe M, Lillis R, Martin DH, Ferris MJ. Quantitative PCR assessments of bacterial species in women with and without bacterial vaginosis. J Clin Microbiol. 2010 May; 48 (5): 1812–9. DOI: 10.1128/JCM.00851–09.

29. Castro J, Jefferson KK, Cerca N. Genetic Heterogeneity and Taxonomic Diversity among Gardnerella Species. Trends Microbiol. 2020 Mar; 28 (3): 202–211. DOI: 10.1016/j.tim.2019.10.002. Epub 2019 Nov 4. PMID: 31699644.

30. Castro J, Machado D, Cerca N. Unveiling the role of Gardnerella vaginalis in polymicrobial Bacterial Vaginosis bioflms: the impact of other vaginal pathogens living as neighbors. ISME J. 2019 May; 13 (5): 1306–1317. DOI: 10.1038/s41396–018–0337–0. Epub 2019 Jan 22. PMID: 30670827. PMCID: PMC6474217.

31. Machado A, Cerca N. Multiplex Peptide Nucleic Acid Fluorescence in Situ Hybridization (PNA-FISH) for Diagnosis of Bacterial Vaginosis. Methods Mol Biol. 2017; 1616: 209–219. DOI: 10.1007/978–1–4939–7037–7_13. PMID: 28600771.


Review

For citations:


Krysanova A.A., Gushchin A.E., Savicheva A.M. Significance of Gardnerella vaginalis genotyping in diagnosis of recurrent bacterial vaginosis. Medical alphabet. 2021;1(30):48-52. (In Russ.) https://doi.org/10.33667/2078-5631-2021-30-48-52

Views: 664


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2078-5631 (Print)
ISSN 2949-2807 (Online)